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Background: Acute viral respiratory illnesses in children in sub-Saharan Africa have received relatively little
attention, although they are much more frequent causes of morbidity and mortality than in developed countries.
Active surveillance is essential to identify the causative agents and to improve clinical management, especially in
the context of possible circulation of pandemic viruses.
Findings: A prospective study was conducted in the Central African Republic (CAR) between January and
December 2010 among infants and children aged 0–15 years attending sentinel sites for influenza-like illness or
acute respiratory illness. Nasopharyngeal swabs were collected, and one-step real-time and multiplex reverse
transcription-polymerase chain reaction were used to detect respiratory viruses. Respiratory viruses were detected in
49 of the 329 (14.9%) nasopharyngeal samples: 29 (8.8%) contained influenza viruses (5 (1.5%) had pandemic
influenza A/H1N1 virus and 24 (7.3%) had influenza B viruses), 11 (3.3%) contained parainfluenza viruses types 1 and
3 and 9 (2.7%) contained human respiratory syncytial virus. Most cases were detected during the rainy season in
the CAR. Analysis of the amplicon sequences confirmed the identity of each detected virus.
Conclusions: The influenza surveillance system in the CAR has provided valuable data on the seasonality of
influenza and the circulation of other respiratory viruses. Our network could therefore play a valuable role in the
prevention and control of influenza epidemics in the CAR.
Keywords: Molecular diagnosis, Acute respiratory illness, Pandemic influenza A/H1N1 2009, Influenza B, Respiratory
syncytial virus, Parainfluenza virus, Pediatric patientsFinding
Although acute respiratory illness is a major cause of
morbidity and mortality among children in sub-Saharan
Africa, it has received relatively little attention [1]. This
is unfortunate, as underlying diseases such as AIDS,
malaria and tuberculosis, which are highly prevalent in
the region, can worsen such illnesses [2]. The respiratory
viruses known to cause acute illness include human
respiratory syncytial virus (HRSV), human parainfluenza
virus (PIV), human metapneumovirus and influenza
viruses [3-5]. Until recently, the burden of influenza and* Correspondence: mirdad.kazanji@pasteur.fr
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reproduction in any medium, provided the orinfluenza-like illness in Africa was considered to be neg-
ligible [6], mainly because of the lack of confirmation
assays. Reports from Cameroon and Senegal, however,
show that influenza viruses are actively circulating and
may be causing regular epidemics [7,8].
A clear picture of the contribution of each pathogen
to acute respiratory illness is needed in order to improve
prevention and clinical management and consequently
to reduce the burden of disease. The emergence of the
novel influenza A/H1N1 of swine origin in Mexico in
April 2009 and its rapid spread worldwide, causing a
global pandemic, led the health authorities of the
Central African Republic (CAR) to collaborate with the
World Health Organization in strengthening biological
surveillance of acute respiratory illness.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.virologyj.com/content/10/1/49The aim of the study reported here was to determine
the circulation of 2009 pandemic influenza A/H1N1 virus
(H1N1pdm09) by molecular methods and to identify the
causative viruses, the incidence and the clinical features of
acute respiratory illness among infants and young children
at sentinel sites in Bangui and three rural areas.
All infants and children aged between 0–15 years who
attended sentinel sites in Bangui and three rural areas
(Figure 1) for influenza-like illness (ILI) or severe acute
respiratory illness between January and December 2010
were included in the study (Figure 2A). The World
Health Organization definitions were used for ILI
(sudden onset of fever of > 38°C and cough or sore
throat in the absence of other diagnoses) and severe
acute respiratory illness (ILI symptoms and shortness of
breath or difficulty in breathing and requiring hospital
admission). The study protocol was approved by the
National Ethics Committee of the CAR. Individual writ-
ten informed consent was sought from the parents or
guardians of all participants.
Nasopharyngeal samples were collected from 329
infants and children and within 48 hrs at 4°C to the
National Influenza Centre by using rayon-budded swabs
with virus transport medium pre-impregnated sponge






Figure 1 Locations of sentinel sites for surveillance of influenza and rRNA was extracted with a QIAmp RNA mini kit
(Qiagen) according to the manufacturer’s instructions.
Influenza A viruses were detected with a previously
described assay targeting the conserved matrix gene for
universal detection of these viruses [9], and H1N1pdm09
virus was identified with a specific one-step real-time re-
verse transcription-polymerase chain reaction (RT-PCR)
assay (designed by the National Influenza Centre of
northern France, Institut Pasteur, Paris; primers and
probe available upon request at grippe@pasteur.fr). All
specimens were also tested for other respiratory viruses in
two previously described multiplex semi-nested RT-PCR
assays for detecting influenza A and B viruses, HRSV,
human metapneumovirus and PIV types 1, 2, 3 and 4
[10,11]. All assays were performed on an ABI 7500 plat-
form (Applied Biosystems, Foster City, California, USA)
with the SuperScript III Platinum One-step Quantitative
RT-PCR System (Invitrogen, Carlsbad, California, USA). A
specimen was considered positive if the signal curve
crossed the threshold line within 40 cycles. The assay limit
of detection for pandemic H1N1pdm09 influenza virus is
of order of magnitude of 10 copies/μL of initial sample
[9]. The assay limit of detection for influenza A and B
viruses, HRSV, human metapneumovirus and PIV-3 is of
order of magnitude of 10 copies/μL [10]. For PIV-4, theOubangui river 
espiratory viruses in the Central African Republic.
Figure 2 Seasonal patterns of influenza and other respiratory viruses in the Central African Republic. (A) monthly numbers of infants and
children included in the study with detection rate of total respiratory viruses. (B) monthly numbers of cases of influenza and other respiratory
viral illness. The dry season is December–May (yellow line), and the rainy season is June–November (green line).
Nakouné et al. Virology Journal 2013, 10:49 Page 3 of 6
http://www.virologyj.com/content/10/1/49assay limit of detection is of order of magnitude of
100 copies copies/μL, and for PIV-1 and −2, 1000
copies/μL [10]. After amplification, the PCR products
were purified and sent to GATC Biotech (Konstanz,
Germany) for sequencing.
Student’s t test and the Pearson chi-squared test were
used to assess intergroup differences. Statistical analyses
were performed with EpiInfo software (V 3.5.1 CDC).
A test was considered significant when the p value
was < 0.05. The newly obtained sequences were analysed
and compared with sequences available in GenBank.
Results and discussion
Of the 329 patients included in the study, 49 (14.8%)
tested positive for respiratory viruses (Table 1). Of these,
five (1.5%) were positive for H1N1pdm09, 23 (6.9%) for
influenza B, 10 (3.0%) for HRSV and 11 (3.3%) for PIV-1
and −3 (Table 1 and Figure 2B). The average age of posi-
tive patients was 41 months (range, 1 month to 9 years),with no difference in the age or gender distribution. All
samples were negative for human metapneumovirus.
The first case of H1N1pdm09 was detected in the CAR
on 26 July 2010 in a child aged 36 months, followed by a
second case on 11 September in an infant aged 16 months,
and three cases were found in young children on 4, 11
and 22 October (Figure 2B). Of the five children, only one
was admitted to intensive care for respiratory distress; no
deaths were recorded. A 253-bp fragment of the haem-
agglutinin gene of the five H1N1pdm09 strains [accession
numbers: CY092425, CY092426, CY092427, CY092428,
CY092429] showed high sequence similarity (99–100%) to
influenza A/California/04/2009 (H1N1) (data not shown).
The 23 specimens positive for influenza B represented
82.1% of the influenza viruses detected. Ten of the
patients were hospitalized; one infant aged 9 months
died 2 days after admission to intensive care with a clin-
ical picture of severe acute respiratory illness. Influenza
B virus was implicated in respiratory infections
Table 1 Respiratory viruses identified in swab samples from 329 patients with influenza-like illness in Bangui, Central
African Republic, by age group
Age group Number of cases Respiratory virus detected (N positive/N tested (%))
H1N1pdm09 RSV PIV 1 PIV 3 Influenza B All
0-6 m 61 0/61 3/61 (4.9) 1/61 (1.6) 2/61 (3.3) 5/61 (8.2) 11/61 (18.0)
6 m-1y 73 0/73 2/73 (2.7) 2/73 (2.7) 2/73 (2.7) 7/73 (9.6) 13/73 (17.8)
1-2y 123 2/123 (1.6) 2/123 (1.6) 1/123 (0.8) 2/123 (1.6) 8/123 (6.5) 15/123 (12.2)
2-5y 49 2/49 (4.0) 2/49 (4.0) 0/49 1/49 (2.0) 3/49 (6.1) 8/49 (16.3)
6-15y 23 1/23 (4.3) 1/23 (4.3) 0/23 0/23 0/23 2/23 (8.6)
All 329 5/329 (1.5) 10/329 (3.0) 4/329 (1.2) 7/329 (2.1) 23/329 (6.9) 49/329 (14.8)
m, months; y, years, H1N1pdm09, pandemic influenza A/H1N1 2009; RSV, respiratory syncytial virus; PIV, parainfluenza virus.
Nakouné et al. Virology Journal 2013, 10:49 Page 4 of 6
http://www.virologyj.com/content/10/1/49throughout the year, with two peaks: a first (11 positive
samples) at the beginning of the rainy season and a sec-
ond (8 positive samples) in November at the end of the
rainy season (Figure 2B).
Partial genome analysis of nine amplified samples of in-
fluenza B virus [accession numbers: HE803088, HE803089,
HE803090, HE803091, HE803092, HE803093, HE803094,
HE803095] demonstrated high nucleotide similarity (98%)
to vaccine strain B/Victoria/02/1987, except for one that
belonged to the Yamagata lineage (data not shown).
HRSV was detected in 10 patients (Table 1) with a me-
dian age of 28 months, mainly in November (Figure 2B).
One infant aged 10 months died 1 day after admission
to intensive care with a clinical picture of fever, cough,
rhinitis, bronchiolitis, dyspnoea and myalgia. Fever and
rhinitis were recorded in 9 of the 10 patients, and all had
cough. No viral co-infections were reported. Analysis of
the nucleotide sequences of six isolates [accession
numbers: HE803082, HE803083, HE803084, HE803085,
HE803086, HE803087] showed sequence similarity to
both genotypes A and B.
PIV-3 was detected in seven patients (median age,
16 months; range, 5–48 months) and PIV-1 in four
infants (median age, 11 months; range, 3–24 months)
between April and November 2010 (Figure 2B).
Respiratory viruses were found in 14.8% of the 329
collected samples, showing the presence of H1N1pdm09
infections in the CAR for the first time. We found that
influenza B, PIV-1, PIV-3 and HRSV were also involved
in ILI in the country. Most of the cases were detected
during the rainy season.
H1N1pdm09 infection in the CAR was first described
in July 2010. In other African countries, the virus was
shown to have been introduced by travellers [12-14], but
its source in the CAR has not been elucidated. All four
cases detected were indigenous, with no history of travel
or contact with a person returning from a country with
declared cases. Extensive investigations of contacts of
the confirmed cases did not reveal any other cases, sug-
gesting low dissemination of H1N1pdm09 in the coun-
try. The clinical picture of H1N1pdm09 infection wassimilar to that of seasonal influenza circulating before
the pandemic. This is in accordance with studies show-
ing relatively low transmissibility and severity of
H1N1pdm09 [15,16]. Consequently, H1N1pdm09 did
not appear to have had a significant public health impact
in this area of the world.
In the present study, influenza B virus was the most
commonly detected respiratory virus (n=23), whereas in
similar studies in Africa HRSV was the most frequent
causative virus of ILI [17-19]. Influenza B virus caused
respiratory infections throughout the year, with two peaks:
at the beginning of the rainy season (June–July) and at the
end of the rainy season (November). Antigenically and
genetically distinct lineages of influenza B virus, influenza
B/Victoria and B/Yamagata viruses have circulated in the
CAR [20].
HRSV is a major cause of ILI among infants and chil-
dren worldwide [21] and is the most frequently detected
respiratory virus in both developed and developing
countries [17-19,22-26]. In this study, HRSV was found
in only 2.7% of the samples and represented 18.3% of
the viruses detected. The difference from other studies
might be due to a different epidemiology of HRSV in the
CAR, a landlocked country in central Africa, or to differ-
ent inclusion criteria or detection techniques. Most of
HRSV cases detected in our study occurred between
November and February, corresponding to the dry sea-
son in the CAR.
Another interesting finding was the relatively low
prevalence of respiratory viruses in the children with ILI,
which were present in only 14.9% of samples; in similar
studies, as many as 50% of samples contained respiratory
viruses [17-19,22-26]. In the CAR, vaccines against
Streptococcus pneumoniae and Haemophilus influenzae
were introduced in the enlarged programme of vaccin-
ation only recently (H. influenzae in September 2008
and S. pneumoniae in July 2011). In a study in Bangui in
1995, these bacteria were found in hundreds of ill chil-
dren aged less than 5 years [27]. It is therefore likely that
these bacteria are still very common or even the main
causes of respiratory infections in the CAR, as in other
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most severe respiratory infections were due to bacterial
infections, and S. pneumoniae and H. influenzae were
the commonest bacterial causes [28-30]. This may ex-
plain, at least partly, the differences between our results
and those of other studies. It is also possible that viruses
other than these we looked for were involved, such as
human rhinovirus, human bocavirus, human coronavirus
or adenovirus.
The main limitation of our study is the limited sample
size, which prevented us from investigating associations
between clinical outcome and viral etiology. Another
weakness is a bias toward younger patients, so that we
could not assess whether a particular age group is at
greater risk for a specific infection. Owing to the design
of the study, it is also difficult to determine prevalence
from the results. Therefore, further studies are needed
to evaluate the burden of all respiratory viruses infec-
tions in the general population of the CAR.
Our study does highlight the importance of the clin-
ical, epidemiological and virological network for influ-
enza surveillance in the CAR [31,32].
We reported here the first data on the etiology of ILI in
the CAR. This will help central African clinicians to pro-
vide better care and treatment for patients presenting with
ILI, including better use of antibiotics. Further studies
with more patients are needed to confirm the burden of
viral respiratory diseases in the CAR. Collection of sam-
ples from healthy control children may also enable com-
ment on virus detection and disease association. Another
suggestion for future studies is to collect data about
underlying health status of children as risk factors such as
HIV infection, malaria, malnutrition, etc. might have an
impact on the acute respiratory infections [33,34]. The
temporal patterns detected should be assessed over many
years in order to identify long-term seasonal patterns.
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